Aspekt Solutions Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Aspekt Solutions's estimated annual revenue is currently $35.6M per year.(i)
  • Aspekt Solutions's estimated revenue per employee is $349,412

Employee Data

  • Aspekt Solutions has 102 Employees.(i)
  • Aspekt Solutions grew their employee count by 55% last year.

Aspekt Solutions's People

NameTitleEmail/Phone
1
Chief PhysicistReveal Email/Phone
2
VPReveal Email/Phone
3
Operations Manager, DiagnosticReveal Email/Phone
4
Senior Certified Medical DosimetristReveal Email/Phone
5
Senior Medical DosimetristReveal Email/Phone
6
Medical Physics AssistantReveal Email/Phone
7
Special Project CoordinatorReveal Email/Phone
8
Radiation Oncology PhysicistReveal Email/Phone
9
Sr. Medical PhysicistReveal Email/Phone
10
Diagnostic Medical PhysicistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$47.2M1596%N/AN/A
#2
$740.1M19588%N/AN/A
#3
$85.8M2898%N/AN/A
#4
$4M2117%N/AN/A
#5
$16M66-6%N/AN/A
#6
$49.3M1669%N/AN/A
#7
$16M668%N/AN/A
#8
$7.6M350%N/AN/A
#9
$7.6M35-3%N/AN/A
#10
$8.4M3911%N/AN/A
Add Company

What Is Aspekt Solutions?

Aspekt Solutions offers radiology and radiation oncology providers the staff, guidance, and expertise they need to turn a high-risk, high-capital business into a competitive advantage. Aspekt can be the trusted partner you need to support and extend radiation programs and prepare for the future. With physics at the core of who we are, we bring more than 100 technical, clinical and operational experts who combine breadth and scale with the highest standard of scientific excellence. We have decades of experience and several clients who have worked with us since our inception.

keywords:N/A

N/A

Total Funding

102

Number of Employees

$35.6M

Revenue (est)

55%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$33.9M1100%N/A
#2
$33.4M11524%N/A
#3
$3.5M16323%N/A
#4
$27.4M17224%N/A
#5
$40.4M1755%N/A